The Future of Pharmaceutical Distribution (with abstract)
| The Future of Pharmaceutical Distribution (with abstract) | |
|---|---|
| Published By | [[Zaelab]] |
| Publish Date | August 21, 2023 |
| Authors | Evan Klein |
| Topics | B2B eCommerce in Pharma |
| Statistics | |
| Article Size | words |
| Diagrams | No |
| Downloadable Version | No |
| Reviewers | |
| Page Owner | Nikolay Sidelnikov |
| Summary Author | Nikolay Sidelnikov |
Abstract
The article The Future of Pharmaceutical Distribution was published by Zaelab in 2023, and is devoted to pharmaceutical distribution predictions, and explains how technologies will change B2B interactions in the industry.
In general, the author highlights two main trends:
- Pharmaceutical companies will move towards direct-to-consumer (DTC) distribution, especially for over-the-counter products, gaining control over brand presentation and customer experience.
- They will streamline distribution processes and enhance transparency within the supply chain due to such technologies as artificial intelligence (AI), machine learning, and blockchain.
The following challenges are mentioned:
- New technology requires aligning with existing heavy regulations and gaining approvals from regulatory bodies.
- Pharmaceutical companies handle sensitive patient data, intellectual property, and proprietary research information.
In addition to DTC trend, the route of how medications are accessed and distributed is changing. Online pharmacies offer patients greater convenience, a wider range of products, and direct access to pharmaceutical manufacturers or authorized distributors, leading to potential cost savings and more efficient inventory management.
Another important trend is about creating a unified sales and marketing strategy, that would ensure a consistent message across all stakeholder touchpoints.
Full article: The Future of Pharmaceutical Distribution